SEARCH

SEARCH BY CITATION

References

  • 1
    Newton M, Bryan R, Burnham WR, et al. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett’s oesophagus . Gut 1997; 40: 9 13.
  • 2
    Csendes A, Smok G, Cerda G, et al. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflx, erosive esophagitis or Barrett’s esophagus . Dis Esophagus 1997; 10: 38 42.
  • 3
    Werdmuller BFM & Loffeld Rjlf. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 1997; 42: 103 5.
  • 4
    Hackelsberger A, Schultze V, Günther T, et al. The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case-control study. Eur J Gastroenterol Hepatol 1998; 10: 465 8.
  • 5
    Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998; 115: 50 7.
  • 6
    Chow W, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58: 588 90.
  • 7
    Labenz J, Blum AL, Bayerdörffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442 7.
  • 8
    Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110: 725 32.
  • 9
    Labenz J, Tillenburg B, Peitz U, et al. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer. Gut 1997; 41: 33 6.
  • 10
    Paull A, Trier JS, Dalton MD, et al. The histologic spectrum of Barrett’s esophagus. N Engl J Med 1976; 295: 476 80.
  • 11
    Peña AS, Endtz HP, Offerhaus GJA, et al. Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion 1989; 44: 131 41.
  • 12
    Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Helicobacter pylori and the efficacy of omeprazole therapy for gastro-esophageal reflux disease. Am J Gastroenterol 1999; in press.
  • 13
    Talley NJ, Janssens J, Lauritsen K, et al. No increase of reflux symptoms or esophagitis in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial. Gastroenterology 1998; 114: A306A306(Abstract).
  • 14
    Malfertheiner P, Veldhuyzen van Zanten S, Dent J, et al. Does cure of Helicobacter pylori infection induce heartburn? Gastroenterology 1998; 114: A212A212(Abstract).
  • 15
    Verdú EF, Armstrong D, Idström J-P, et al. Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis . Scand J Gastroenterol 1996; 31: 1151 6.
  • 16
    Labenz J, Tillenburg B, Peitz U, et al. Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients. Am J Gastroenterol 1997; 92: 576 81.
  • 17
    Hatlebakk JG & Berstad A. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis. Scand J Gastroenterol 1996; 31: 954 8.